Pediatrix Medical (MD) EBITDA Margin (2009 - 2026)
Pediatrix Medical's (MD) quarterly EBITDA Margin came in at 11.67% in Q2 2026, down 110.0% year-over-year from 116.7% in Q2 2025, and up 33.4% quarter-over-quarter from 8.75% in Q1 2026.
Powered by 
Analysis
Pediatrix Medical (MD) EBITDA Margin (2009 - 2026) Analysis & Trends
Pediatrix Medical (MD) has reported EBITDA Margin for 18 consecutive years, with 11.67% the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBITDA Margin fell 110.0% year-over-year to 11.67% in Q2 2026; TTM through Jun 2026 was 11.04%, a 254.0% increase from a year earlier, with the FY2025 full-year figure at 11.66%, up 1394.0% from the prior year.
- EBITDA Margin was 11.67% for Q2 2026 at Pediatrix Medical, up from 8.75% in the prior quarter.
- Over five years, EBITDA Margin peaked at 13.81% in Q3 2025 and troughed at 31.28% in Q2 2024.
- A 5-year average of 4.81% and a median of 8.03% in 2022 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin sank 4096 bps in 2024 and jumped 4404 bps in 2025, its largest moves.
- Over 5 years, EBITDA Margin stood at 7.01% in 2022, then tumbled by 420 bps to 22.46% in 2023, then soared by 135 bps to 7.82% in 2024, then gained by 26 bps to 9.88% in 2025, then increased by 18 bps to 11.67% in 2026.
- The last three EBITDA Margin figures came in at 11.67% (Q2 2026), 8.75% (Q1 2026), and 9.88% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.76 Bn | 12.64 Bn | 1.16 Bn | 16.29% |
| 2 | RadNet | 5.80 Bn | 5.37 Bn | 88.08 Mn | 6.34% |
| 3 | Concentra Group Holdings Parent | 4.40 Bn | 4.26 Bn | 192.10 Mn | 18.99% |
| 4 | Privia Health | 2.61 Bn | 2.25 Bn | - | 1.88% |
| 5 | Pediatrix Medical | 2.20 Bn | 1.79 Bn | - | 11.67% |
| 6 | Fresenius Medical Care AG | 2.11 Bn | 1.41 Bn | 1.52 Bn | 9.58% |
| 7 | Progyny | 2.01 Bn | 1.77 Bn | 89.30 Mn | 11.41% |
| 8 | Surgery Partners | 1.87 Bn | 3.08 Bn | 622.10 Mn | 12.03% |
| 9 | U S Physical Therapy | 1.18 Bn | 1.47 Bn | 41.94 Mn | 10.25% |
| 10 | Starling Oncology | 595.78 Mn | 554.69 Mn | 27.17 Mn | -2.17% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.67% |
| Mar 31, 2026 | 8.75% |
| Dec 31, 2025 | 9.88% |
| Sep 30, 2025 | 13.81% |
| Jun 30, 2025 | 12.77% |
| Mar 31, 2025 | 7.00% |
| Dec 31, 2024 | 7.82% |
| Sep 30, 2024 | 6.62% |
| Jun 30, 2024 | -31.28% |
| Mar 31, 2024 | 3.21% |
| Dec 31, 2023 | -22.46% |
| Sep 30, 2023 | 7.95% |
| Jun 30, 2023 | 9.69% |
| Mar 31, 2023 | 6.12% |
| Dec 31, 2022 | 7.01% |
| Sep 30, 2022 | 9.67% |
| Jun 30, 2022 | 10.32% |
| Mar 31, 2022 | 8.11% |
| Dec 31, 2021 | 13.64% |
| Sep 30, 2021 | 11.93% |